Our Team

Pinney Associates is pleased to announce the company’s new leadership team. Joe Gitchell is our new CEO, Lucy Owen is our new President, and Judy Ashworth has been promoted to Senior Vice President.

Pinney Associates’ founder, John Pinney, is now Founder and Chair.

Lucy Owen

Guiding clients through the complex and dynamic Rx-to-OTC switch regulatory process

Saul Shiffman, PhD

Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis

Directing support for Rx-to-OTC switch, with emphasis on behavioral data and communication

Bernie Simone

Vice President, Client Strategy and Rx-to-OTC Switch

Steering OTC switch projects through regulatory and commercial challenges to success

George Quesnelle

Senior Strategic Advisor, OTC Commercialization and Optimization

Marshalling onset-to-completion resources for Rx-to-OTC switch success

Christine Sweeney, PhD, MPH

Director, Issues Management

Establishing the data driven benefit-risk case to support regulatory approval of consumer healthcare products

Lisa Zapawa, MD, MPH

Director, Medical Science

Providing scientific and strategic support for Rx-to-OTC switch efforts

Karen Sees, DO

Senior Scientific Advisor, Drug Development and Pharmacovigilance

Speak to an expert.